References
- 1
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K.
Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
Nature.
1999;
402
656-660
- 2
Wren A M, Small C J, Ward H L, Murphy K G, Dakin C L, Taheri S. et al .
The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion.
Endocrinology.
2000;
141
4325-4328
- 3
Tschop M, Smiley D L, Heiman M L.
Ghrelin induces adiposity in rodents.
Nature.
2000;
407
908-913
- 4
Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K. et al .
A role for ghrelin in the central regulation of feeding.
Nature.
2001;
409
194-198
- 5
Wren A M, Small C J, Abbott C R, Dhillo W S, Seal L J, Cohen M A. et al .
Ghrelin causes hyperphagia and obesity in rats.
Diabetes.
2001;
50
2540-2547
- 6
Arvat E, Maccario M, di Vito L, Broglio F, Benso A, Gottero C. et al .
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans:
Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing
hormone.
J Clin Endocrinol Metab.
2001;
86
1169-1174
- 7
Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z. et al .
Ghrelin stimulates gastric acid secretion and motility in rats.
Biochem Biophys Res Commun .
2000;
276
905-908
- 8
Flint A, Raben A, Astrup A, Holst J J.
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
J Clin Invest.
1998;
101
515-520
- 9
Verdich C, Toubro S, Buemann B, Lysgard M J, Juul H J, Astrup A.
The role of postprandial releases of insulin and incretin hormones in meal-induced
satiety-effect of obesity and weight reduction.
Int J Obes Relat Metab Disord.
2001;
25
1206-1214
- 10
Rodriguez d e, Navarro M, Alvarez E, Roncero I, Chowen J A, Maestre O. et al .
Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on
satiety and body weight loss in Zucker obese rats.
Metabolism.
2000;
49
709-717
- 11
Orskov L, Holst J J, Moller J, Orskov C, Moller N, Alberti K G. et al .
GLP-1 does not acutely affect insulin sensitivity in healthy man.
Diabetologia.
1996;
39
1227-1232
- 12
Villanueva-Penacarrillo M L, Marquez L, Gonzalez N, Diaz-Miguel M, Valverde I.
Effect of GLP-1 on lipid metabolism in human adipocytes.
Horm Metab Res.
2001;
33
73-77
- 13
Berlin E, Arner P, Bolinder J, Hagstrom-Toft E.
Action of glucagon and glucagon-like peptide-I-(7-36) amide on lipolysis in human
subcutaneous adipose tissue and skeletal muscle in vivo. J.
Clin Endocrinol Metab.
2001;
86
1229-1234
- 14
Hosoda H, Kojima M, Matsuo H, Kangawa K.
Ghrelin and des-acyl ghrelin: Two major forms of rat ghrelin peptide in gastrointestinal
tissue.
Biochem Biophys Res Commun.
2000;
279
909-913
- 15
Orskov C, Rabenhoj L, Wettergren A, Kofod H, Hoist J J.
Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide
I in humans.
Diabetes.
1994;
43
535-539
- 16
Cummings D E, Pumell J Q, Frayo R S, Schmidova K, Wisse B E, Weigle D S.
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in
humans.
Diabetes.
2001;
50
1714-1719
C. B. Djurhuus
Medical Department M (Endocrinology & Diabetes), Aarhus University Hospital ·
Norrebrogade 42 - 44 · 8000 Aarhus C · Denmark ·
Phone: + 45 (89) 49 20 71
Fax: + 45 (89) 49 20 10 ·
Email: cbd@dadlnet.dk
